Hybrid coronary revascularization (HCR) is an emerging approach for multivessel coronary artery disease that combines the excellent long-term outcomes of surgery with the faster recovery and reduced short-term complications of percutaneous coronary intervention. This review addresses the features of HCR, including patient selection and effectiveness.
No takes yet. Share an insight, caveat, or question.
Yoshitsugu Nakamura (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: